Mirtazapine (30 mg tablets): Supply issue
Due to flooding in the country where mirtazapine is made, a shipment of mirtazapine 30 mg tablets was delayed.
1 October 2026 | Monitoring continues
A shipment arrived late September 2026. A larger shipment is expected to arrive by the end of October, this will return stock levels to normal.
Affected product
There is delay for the next shipment of the following product:
Mirtazapine
- Presentation: Tab 30 mg
- Brand: Noumed
- Pharmacode: 2678802
- Subsidy: $2.34
- Measure / Qty: per 30
Schedule listing for mirtazapine(external link)
The 45 mg tablet remains available.
People who take mirtazapine
If you are unable to access mirtazapine, we're sorry. We know how important this treatment is.
You can talk to the person who prescribes your mirtazapine, about your treatment options.
Expected resupply
A shipment arrived late September 2026. A larger shipment is expected to arrive by the end of October, this will return stock levels to normal.
We are working closely with the supplier and wholesalers to support distribution as quickly as possible, once stock becomes available.
Who to contact
If you have questions about this issue, email enquiry@pharmac.govt.nz
Please include as much information as you can about the product (presentation, brand, pharmacode) and who your wholesaler is.
Sign up to our email list for regular emails about supply issues and more(external link)